Publication | Open Access
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
80
Citations
26
References
2019
Year
Our findings demonstrate that CAR T cells targeting CD79b alone or in combination have promise for treating and preventing CD19 antigen escape in B-cell lymphomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1